https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51276 Tue 29 Aug 2023 15:47:54 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:37301 Thu 24 Oct 2024 15:55:14 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45665 n = 9; 8.1%). Women with antepartum eclampsia (n = 58, 42.6%) were more likely to have a preterm birth (P = 0.04). Sixty-three (47.4%) women had pre-eclampsia diagnosed prior to their first eclamptic seizure of whom 19 (30.2%) received magnesium sulphate prior to the first seizure. Nearly all women (n = 128; 95.5%) received magnesium sulphate post-seizure. No woman received prophylactic aspirin during pregnancy. Five women had a cerebrovascular haemorrhage, and there were five known perinatal deaths. Conclusions: Eclampsia is an uncommon consequence of pre-eclampsia in ANZ. There is scope to reduce the incidence of this condition, associated with often catastrophic morbidity, through the use of low-dose aspirin and magnesium sulphate in women at higher risk.]]> Thu 23 Mar 2023 13:59:47 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29055 Sat 24 Mar 2018 07:37:18 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:44748 Mon 24 Oct 2022 08:42:25 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41870 Mon 15 Aug 2022 16:00:26 AEST ]]>